← Leaderboards
Marcel R M Van Den Brink
Sloan-Kettering Institute For Cancer Res
$40,856,878
Attributed
$44,969,048
Total exposure
22
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,366,065 · 23
By mechanism
R01$35,446,279 · 12
P01$16,805,145 · 10
R35$3,114,641 · 1
Top collaborators
- Ken Hashigiwa Cadwell8 shared
- Doris Ponce3 shared
- Justin Cross2 shared
- Philip Lorenzi1 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- David A Scheinberg$21,198,583
- Richard J O'Reilly$17,498,839
- Howard T. Petrie$13,634,295
- James W. Young$11,235,643
- Ronald G Blasberg$11,404,709
Others in their field
Top investigators on “Allogenic”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$40,815,122
- Bruce R. Blazar · University Of Minnesota$37,193,531
- Megan Sykes · Columbia University Health Sciences$33,587,479
- Pavan Reddy · University Of Michigan At Ann Arbor$29,828,658
Research focus
AllogenicInfectionT-LymphocyteTransplantationPreclinical StudyHematopoietic Stem Cell TransplantationMorbidity - Disease RateRelapseMalignant - DescriptorImmuneConditioningClinical TrialsReconstitutionMortalityBaseImmunityCellsIntestinesTransplant RecipientsRecoveryMalignant NeoplasmsMediatingTissuesBone Marrow Transplantation
Grant awards (110)
The role of the intestinal microbiome in cancer immunotherapy$1,038,040
R35 · FY2025 · CA · contact PI
The role of bile acid metabolomics in graft-versus-host disease$585,843
R01 · FY2025 · CA · contact PI
Intestinal microbiome restoration in allogeneic stem cell transplantation$442,500
R01 · FY2025 · HL
The role of the intestinal microbiome in cancer immunotherapy$1,014,601
R35 · FY2024 · CA · contact PI
The role of bile acid metabolomics in graft-versus-host disease$555,619
R01 · FY2024 · CA · contact PI
Intestinal microbiome restoration in allogeneic stem cell transplantation$442,500
R01 · FY2024 · HL
The role of the intestinal microbiome in cancer immunotherapy$758,368
R35 · FY2023 · CA · contact PI
The role of bile acid metabolomics in graft-versus-host disease$584,482
R01 · FY2023 · CA · contact PI
Intestinal microbiome restoration in allogeneic stem cell transplantation$442,500
R01 · FY2023 · HL
The role of the intestinal microbiome in cancer immunotherapy$303,632
R35 · FY2023 · CA · contact PI
Immunobiology of Allogeneic Hematopoietic Cell Transplantation$2,522,125
P01 · FY2022 · CA · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Renewal - 1$719,259
R01 · FY2022 · HL
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT$663,330
R01 · FY2022 · HL · contact PI
The role of intestinal microbiota in graft-versus-host disease$539,154
R01 · FY2022 · CA · contact PI
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation$514,445
R01 · FY2022 · CA · contact PI
Project 2: Microbiota-based biomarkers and therapeutic strategies for intestinal graft vs host disease$385,143
P01 · FY2022 · CA · contact PI
Core A: Administrative Core$108,885
P01 · FY2022 · CA · contact PI
The role of intestinal microbiota in graft-versus-host disease$41,296
R01 · FY2022 · CA · contact PI
Immunobiology of Allogeneic Hematopoietic Cell Transplantation$2,573,596
P01 · FY2021 · CA · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Renewal - 1$719,259
R01 · FY2021 · HL
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT$663,330
R01 · FY2021 · HL · contact PI
The role of intestinal microbiota in graft-versus-host disease$550,156
R01 · FY2021 · CA · contact PI
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation$524,944
R01 · FY2021 · CA · contact PI
Project 2: Microbiota-based biomarkers and therapeutic strategies for intestinal graft vs host disease$388,389
P01 · FY2021 · CA · contact PI
Project 2: Thymic and peripheral Aspects of T cell Aging and Rejuvenation$387,422
P01 · FY2021 · AG · contact PI
The role of intestinal microbiota in graft-versus-host disease$123,796
R01 · FY2021 · CA · contact PI
Core A: Administrative Core$105,876
P01 · FY2021 · CA · contact PI
Immunobiology of Allogeneic Hematopoietic Cell Transplantation$77,052
P01 · FY2021 · CA · contact PI
Core A: Administrative Core$77,052
P01 · FY2021 · CA · contact PI
Project 2: Microbiota-based biomarkers and therapeutic strategies for intestinal graft vs host disease$4,029
P01 · FY2021 · CA · contact PI
Immunobiology of Allogeneic Hematopoietic Cell Transplantation$2,573,596
P01 · FY2020 · CA · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Renewal - 1$719,259
R01 · FY2020 · HL
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT$663,330
R01 · FY2020 · HL · contact PI
The role of intestinal microbiota in graft-versus-host disease$550,156
R01 · FY2020 · CA · contact PI
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation$524,944
R01 · FY2020 · CA · contact PI
Project 2: Microbiota-based biomarkers and therapeutic strategies for intestinal graft vs host disease$392,922
P01 · FY2020 · CA · contact PI
Project 2: Thymic and peripheral Aspects of T cell Aging and Rejuvenation$382,864
P01 · FY2020 · AG · contact PI
Core A: Administrative Core$106,379
P01 · FY2020 · CA · contact PI
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy$77,052
P01 · FY2020 · CA · contact PI
The role of intestinal microbiota in graft-versus-host disease$65,205
R01 · FY2020 · CA · contact PI
Project 2: Microbiota-based biomarkers and therapeutic strategies for intestinal graft vs host disease$8,562
P01 · FY2020 · CA · contact PI
Core A: Administrative Core$8,561
P01 · FY2020 · CA · contact PI
Immunobiology of Allogeneic Hematopoietic Cell Transplantation$2,573,596
P01 · FY2019 · CA · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Renewal - 1$736,634
R01 · FY2019 · HL
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT$683,230
R01 · FY2019 · HL · contact PI
The role of intestinal microbiota in graft-versus-host disease$533,651
R01 · FY2019 · CA · contact PI
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation$486,797
R01 · FY2019 · CA · contact PI
Project 2: Microbiota-based biomarkers and therapeutic strategies for intestinal graft vs host disease$392,922
P01 · FY2019 · CA · contact PI
Project 2: Thymic and peripheral Aspects of T cell Aging and Rejuvenation$389,778
P01 · FY2019 · AG · contact PI
Core A: Administrative Core$106,379
P01 · FY2019 · CA · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Resubmission - 1$550,561
R01 · FY2018 · HL
The role of intestinal microbiota in graft-versus-host disease$525,957
R01 · FY2018 · CA · contact PI
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation$501,853
R01 · FY2018 · CA · contact PI
Project 2: Thymic and peripheral Aspects of T cell Aging and Rejuvenation$397,291
P01 · FY2018 · AG · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Resubmission - 1$550,561
R01 · FY2017 · HL
IL-22 and Mucosal Immunity During Bone Marrow Transplantation$378,651
P01 · FY2017 · CA · contact PI
Project 2: Thymic and peripheral Aspects of T cell Aging and Rejuvenation$254,505
P01 · FY2017 · AG · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Resubmission - 1$550,561
R01 · FY2016 · HL
IL-22 in Thymic Regeneration$502,673
R01 · FY2016 · AI · contact PI
Mucosal Immunity and Microbiota in Intestinal Graft-versus-Host Disease$427,942
R01 · FY2016 · AI · contact PI
IL-22 and Mucosal Immunity During Bone Marrow Transplantation$411,187
P01 · FY2016 · CA · contact PI
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Resubmission - 1$624,803
R01 · FY2015 · HL
Strategies to enhance immune reconstitution after bone marrow transplant$580,224
R01 · FY2015 · HL · contact PI
Mucosal Immunity and Microbiota in Intestinal Graft-versus-Host Disease$512,668
R01 · FY2015 · AI · contact PI
IL-22 in Thymic Regeneration$502,673
R01 · FY2015 · AI · contact PI
IL-22 and Mucosal Immunity During Bone Marrow Transplantation$411,187
P01 · FY2015 · CA · contact PI
Strategies to enhance immune reconstitution after bone marrow transplant$577,282
R01 · FY2014 · HL · contact PI
IL-22 in Thymic Regeneration$502,673
R01 · FY2014 · AI · contact PI
Mucosal Immunity and Microbiota in Intestinal Graft-versus-Host Disease$411,525
R01 · FY2014 · AI · contact PI
IL-22 and Mucosal Immunity During Bone Marrow Transplantation$398,852
P01 · FY2014 · CA · contact PI
Mucosal Immunity and Microbiota in Intestinal Graft-versus-Host Disease$82,157
R01 · FY2014 · AI · contact PI
Strategies to enhance immune reconstitution after bone marrow transplant$614,681
R01 · FY2013 · HL · contact PI
IL-22 in Thymic Regeneration$472,513
R01 · FY2013 · AI · contact PI
IL-22 and Mucosal Immunity During Bone Marrow Transplantation$411,187
P01 · FY2013 · CA · contact PI
Mucosal Immunity and Microbiota in Intestinal Graft-versus-Host Disease$386,834
R01 · FY2013 · AI · contact PI
Strategies to enhance immune reconstitution after bone marrow transplant$688,722
R01 · FY2012 · HL · contact PI
IL-22 in Thymic Regeneration$502,673
R01 · FY2012 · AI · contact PI
Strategies to Enhance Lymphoid Recovery After Radiation-Induced Injury$465,302
R01 · FY2012 · AI · contact PI
Mucosal Immunity and Microbiota in Intestinal Graft-versus-Host Disease$411,525
R01 · FY2012 · AI · contact PI
Strategies to enhance immune reconstitution after bone marrow transplant$40,772
R01 · FY2012 · HL · contact PI
Strategies to Enhance Lymphoid Recovery After Radiation-Induced Injury$669,953
R01 · FY2011 · AI · contact PI
Strategies to enhance immune reconstitution after bone marrow transplant$584,742
R01 · FY2011 · HL · contact PI
CEACAM-1a regulates graft-versus-host-disease after allogeneic HSCT$876,767
R01 · FY2010 · HL · contact PI
Strategies to Enhance Lymphoid Recovery After Radiation-Induced Injury$470,003
R01 · FY2010 · AI · contact PI
Strategies to enhance immune reconstitution after BMT$449,088
R01 · FY2010 · HL · contact PI
Strategies to enhance immune reconstitution after BMT$36,666
R01 · FY2010 · HL · contact PI
CEACAM-1a regulates graft-versus-host-disease after allogeneic HSCT$851,391
R01 · FY2009 · HL · contact PI
Strategies to enhance immune reconstitution after BMT$550,838
R01 · FY2009 · HL · contact PI
Strategies to Enhance Lymphoid Recovery After Radiation-Induced Injury$474,750
R01 · FY2009 · AI · contact PI
Strategies to Enhance Post-Transplant Tumor Vaccination$326,165
P01 · FY2009 · CA · contact PI
T cell homing in intestinal graft-versus-host disease$323,957
R01 · FY2009 · CA · contact PI
Strategies to Enhance Lymphoid Recovery After Radiation-Induced Injury$474,750
R01 · FY2008 · AI · contact PI
Strategies to enhance immune reconstitution after BMT$449,088
R01 · FY2008 · HL · contact PI
T cell homing in intestinal graft-versus-host disease$323,957
R01 · FY2008 · CA · contact PI
Strategies to Enhance Post-Transplant Tumor Vaccination$173,940
P01 · FY2008 · CA · contact PI
Strategies to enhance immune reconstitution after BMT$98,050
R01 · FY2008 · HL · contact PI
Strategies to enhance immune reconstitution after BMT$449,088
R01 · FY2007 · HL · contact PI
T cell homing in intestinal graft-versus-host disease$323,957
R01 · FY2007 · CA · contact PI
Strategies to enhance immune reconstitution after BMT$462,500
R01 · FY2006 · HL · contact PI
T cell homing in intestinal graft-versus-host disease$307,727
R01 · FY2006 · CA · contact PI
Strategies to enhance immune reconstitution after BMT$366,750
R01 · FY2005 · HL
The role of TRAIL in bone marrow transplantation$356,625
R01 · FY2005 · HL
T cell homing in intestinal graft-versus-host disease$315,133
R01 · FY2005 · CA
Strategies to enhance immune reconstitution after BMT$366,750
R01 · FY2004 · HL
The role of TRAIL in bone marrow transplantation$356,625
R01 · FY2004 · HL
Strategies to enhance immune reconstitution after BMT$366,750
R01 · FY2003 · HL
The role of TRAIL in bone marrow transplantation$356,625
R01 · FY2003 · HL
Strategies to enhance immune reconstitution after BMT$366,957
R01 · FY2002 · HL
The role of TRAIL in bone marrow transplantation$354,038
R01 · FY2002 · HL
STRATEGIES TO ENHANCE IMMUNE RECONSTITUTION AFTER BMT$0
P01 · FY2002 · CA